Big pharma in focus: What’s driving AstraZeneca and GSK right now

AstraZeneca results are in focus as the FTSE 100 earnings season accelerates. With pharma stocks near record highs, what should investors be watching?

In this week’s market update, Russ Mould looks ahead to upcoming results from AstraZeneca and GSK, two of the UK’s largest pharmaceutical companies. With strong share price performance and ambitious long-term targets, these updates could offer important signals for investors.

In this video, we cover:

• AstraZeneca’s expected Q1 results and 2026 outlook
• GSK’s growth targets and first-quarter expectations
• Key trends in pharma stocks and FTSE 100 earnings
• The importance of drug pipelines and clinical trials
• Risks from tariffs, US policy changes, and healthcare spending

What you’ll learn:

• What analysts expect from AstraZeneca results
• How GSK is positioned for future growth
• What to watch in pharma sector performance
• How macro factors could impact healthcare stocks